Interventions for treating oral candidiasis for patients with cancer receiving treatment
Interventions for treating oral candidiasis for patients with cancer receiving treatment
Cochrane Review
7 SoF Entries
Summary of Findings
Key results and quality assessments using GRADE methodology
| Outcome | Effect | Participants | Studies | Certainty |
|---|---|---|---|---|
|
Apnoea–hypopnoea index (AHI)
No treatment |
0.39 | - | - | Not assessed |
|
Daytime symptoms: Sleepiness
No treatment |
0.64 | - | - | Not assessed |
|
Daytime symptoms: Irritability
No treatment |
0.32 | - | - | Not assessed |
|
Daytime symptoms: Tiredness
No treatment |
0.26 | - | - | Not assessed |
|
Daytime symptoms: School problems
No treatment |
0.64 | - | - | Not assessed |
|
Daytime symptoms: Morning headache
No treatment |
0.39 | - | - | Not assessed |
|
Daytime symptoms: Oral breathing
No treatment |
0.16 | - | - | Not assessed |
GRADE Certainty of Evidence:
High
Very confident in the effect estimate
Moderate
Moderately confident in the effect estimate
Low
Limited confidence in the effect estimate
Very Low
Very little confidence in the effect estimate
Review Information
| Review ID: | CD005520 |
| Outcomes: | 7 assessed |
Related Content
Evidence Quality Distribution:
Not assessed:
7